Analyst consensus rating
Molecular Partners Analyst Rating: Strong Buy
Direct answer
Molecular Partners's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.37.
Forecast evidence checked September 30, 2026.
Get free Molecular Partners email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.90
- Average price target
- $10.37
- High price target
- $16.38
- Low price target
- $3.64
- Low target gap
- -6.8%
- Target upside
- +165.8%
- High target gap
- +319.9%
- Target range width
- 326.7%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- September 30, 2026
- Valid through
- October 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Molecular Partners?
Molecular Partners has a verified Strong Buy consensus. The same dataset has an average price target of $10.37.
How far are Molecular Partners's low and high targets from the recorded price?
The low target implies -6.8%, while the high target implies +319.9%.
How many analysts are included in Molecular Partners's consensus?
The verified consensus includes 5 analysts.
How is Molecular Partners's target upside or downside calculated?
The average target of $10.37 is divided by the recorded price of $3.90, then one is subtracted to produce +165.8%. This does not guarantee a future return.
When was Molecular Partners's analyst forecast verified?
The data was verified on 2026-09-30. The dataset is valid through 2026-10-07.